166 related articles for article (PubMed ID: 7830002)
1. Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-1, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles.
Jacks T; Hickey G; Judith F; Taylor J; Chen H; Krupa D; Feeney W; Schoen W; Ok D; Fisher M
J Endocrinol; 1994 Nov; 143(2):399-406. PubMed ID: 7830002
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and specificity of L-692,429, a novel nonpeptidyl growth hormone secretagogue, in beagles.
Hickey G; Jacks T; Judith F; Taylor J; Schoen WR; Krupa D; Cunningham P; Clark J; Smith RG
Endocrinology; 1994 Feb; 134(2):695-701. PubMed ID: 8299565
[TBL] [Abstract][Full Text] [Related]
3. MK-0677, a potent, novel, orally active growth hormone (GH) secretagogue: GH, insulin-like growth factor I, and other hormonal responses in beagles.
Jacks T; Smith R; Judith F; Schleim K; Frazier E; Chen H; Krupa D; Hora D; Nargund R; Patchett A; Hickey G
Endocrinology; 1996 Dec; 137(12):5284-9. PubMed ID: 8940347
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects.
Aloi JA; Gertz BJ; Hartman ML; Huhn WC; Pezzoli SS; Wittreich JM; Krupa DA; Thorner MO
J Clin Endocrinol Metab; 1994 Oct; 79(4):943-9. PubMed ID: 7962302
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone (GH) and insulin-like growth factor I responses after treatments with an orally active GH secretagogue L-163,255 in swine.
Chang CH; Rickes EL; McGuire L; Frazier E; Chen H; Barakat K; Nargund R; Patchett A; Smith RG; Hickey GJ
Endocrinology; 1996 Nov; 137(11):4851-6. PubMed ID: 8895356
[TBL] [Abstract][Full Text] [Related]
6. Repeat administration of the GH secretagogue MK-0677 increases and maintains elevated IGF-I levels in beagles.
Hickey GJ; Jacks TM; Schleim KD; Frazier E; Chen HY; Krupa D; Feeney W; Nargund RP; Patchett AA; Smith RG
J Endocrinol; 1997 Feb; 152(2):183-92. PubMed ID: 9071975
[TBL] [Abstract][Full Text] [Related]
7. Increases in circulating insulin-like growth factor I levels by the oral growth hormone secretagogue MK-0677 in the beagle are dependent upon pituitary mediation.
Schleim KD; Jacks T; Cunningham P; Feeney W; Frazier EG; Niebauer GW; Zhang D; Chen H; Smith RG; Hickey G
Endocrinology; 1999 Apr; 140(4):1552-8. PubMed ID: 10098487
[TBL] [Abstract][Full Text] [Related]
8. Consistent GH responses to repeated injection of GH-releasing hexapeptide (GHRP-6) and the non-peptide GH secretagogue, L-692,585.
Fairhall KM; Mynett A; Smith RG; Robinson IC
J Endocrinol; 1995 Jun; 145(3):417-26. PubMed ID: 7636426
[TBL] [Abstract][Full Text] [Related]
9. Intranasal administration of His-D-Trp-Ala-Trp-D-Phe-LysNH2 (growth hormone releasing peptide) increased plasma growth hormone and insulin-like growth factor-I levels in normal men.
Hayashi S; Okimura Y; Yagi H; Uchiyama T; Takeshima Y; Shakutsui S; Oohashi S; Bowers CY; Chihara K
Endocrinol Jpn; 1991 Feb; 38(1):15-21. PubMed ID: 1915110
[TBL] [Abstract][Full Text] [Related]
10. Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.
Patchett AA; Nargund RP; Tata JR; Chen MH; Barakat KJ; Johnston DB; Cheng K; Chan WW; Butler B; Hickey G
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):7001-5. PubMed ID: 7624358
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6.
Gertz BJ; Barrett JS; Eisenhandler R; Krupa DA; Wittreich JM; Seibold JR; Schneider SH
J Clin Endocrinol Metab; 1993 Nov; 77(5):1393-7. PubMed ID: 8077339
[TBL] [Abstract][Full Text] [Related]
12. Intracerebroventricular and intravenous administration of growth hormone secretagogue L-692,585, somatostatin, neuropeptide Y and galanin in pig: dose-dependent effects on growth hormone secretion.
Cho SJ; Lee JS; Mathias ED; Chang C; Hickey GJ; Lkhagvadorj S; Anderson LL
Comp Biochem Physiol C Toxicol Pharmacol; 2010 May; 151(4):412-9. PubMed ID: 20074661
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults--a clinical research center study.
Chapman IM; Hartman ML; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1996 Aug; 81(8):2874-80. PubMed ID: 8768844
[TBL] [Abstract][Full Text] [Related]
14. Activity of a novel nonpeptidyl growth hormone secretagogue, L-700,653, in swine.
Chang CH; Rickes EL; Marsilio F; McGuire L; Cosgrove S; Taylor J; Chen H; Feighner S; Clark JN; De Vita R
Endocrinology; 1995 Mar; 136(3):1065-71. PubMed ID: 7867560
[TBL] [Abstract][Full Text] [Related]
15. A novel non-peptidyl growth hormone secretagogue.
Cheng K; Chan WW; Butler B; Wei L; Smith RG
Horm Res; 1993; 40(1-3):109-15. PubMed ID: 7905455
[TBL] [Abstract][Full Text] [Related]
16. Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585.
Hickey GJ; Drisko J; Faidley T; Chang C; Anderson LL; Nicolich S; McGuire L; Rickes E; Krupa D; Feeney W; Friscino B; Cunningham P; Frazier E; Chen H; Laroque P; Smith RG
J Endocrinol; 1996 Feb; 148(2):371-80. PubMed ID: 8699151
[TBL] [Abstract][Full Text] [Related]
17. Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature.
Pihoker C; Badger TM; Reynolds GA; Bowers CY
J Endocrinol; 1997 Oct; 155(1):79-86. PubMed ID: 9390009
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue, in humans.
Gianotti L; Ramunni J; Lanfranco F; Maccagno B; Giordano R; Broglio F; Maccario M; Muller EE; Ghigo E; Arvat E
J Endocrinol Invest; 2001 Feb; 24(2):67-71. PubMed ID: 11263473
[TBL] [Abstract][Full Text] [Related]
19. Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone.
Van den Berghe G; Wouters P; Carlsson L; Baxter RC; Bouillon R; Bowers CY
J Clin Endocrinol Metab; 1998 Sep; 83(9):3062-70. PubMed ID: 9745404
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of growth hormone release from rat primary pituitary cells by L-692,429, a novel non-peptidyl GH secretagogue.
Cheng K; Chan WW; Butler B; Wei L; Schoen WR; Wyvratt MJ; Fisher MH; Smith RG
Endocrinology; 1993 Jun; 132(6):2729-31. PubMed ID: 8389289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
